Clonality Assays and Megakaryocyte Culture Techniques in Essential Thrombocythemia

References

• Fialkow P. J., Faguet G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Lazlo J. Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin. Hematol. 1975; 12: 409–432
   PubMed Web of Science ®Google Scholar
• Mazur E. M., Cohen J. L., Bogart L. Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia. Blood 1988; 71: 1544–1550
   PubMed Web of Science ®Google Scholar
• Vainchenker W., Bouguet J., Guichard J., Breton-Gorius J. Megacaryocyte colony formation from human bone marrow precursors. Blood 1979; 57: 277
   Google Scholar
• Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 1993; 82: 1395–1401
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Lofton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F. T., Mathewes S. L., Bailey M. S., Forstrom J. W., Buddle M. M., Osborn S. G., Evans S. J., Sheppard P. O., Presnell S. R., O'Hara P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565–568
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S., Roth G. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. C-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571–574
   PubMed Web of Science ®Google Scholar
• De Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wang S. C., Kuang W. J., Oles K. J., Hultgren B., Solberg L., Goeddel D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thyrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Bartley T. D., Bogenberger J., Hunt P., Li Y. S., Lu H. S., Martin F., Chang M. S., Samal B., Nichol J. L., Swift S., Johnson M. J., Hsu R. Y., Parker V. P., Suggs S., Skrine J. D., Merewether L. A., Clogston C., Hsu E., Hokom M. M., Hornkhol A., Choi E., Pangelinam M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Wie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Wu W., Del Castillo J., Biron J., Cole S., Hu M. C. T., Pacifici R., Ponting I., Sari C., Wen D., Yung Y. P., Lin H., Bosselman R. A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117–1124
   PubMed Web of Science ®Google Scholar
• Zeigler F. C., De Sauvage F., Ramon W. H., Keller G. A., Donahue C., Schreiber R. D., Malloy B., Hass P., Eaton D., Mattews W. In vitro megakaryocytopoietic and throm-bopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045–4052
   PubMed Web of Science ®Google Scholar
• Hoffman R., Mazur E., Bruno E., Floyd V. Assay of an activity in the serum of patients with disorders of throm-bopoiesis that stimulates formation of megakaryocytic colonies. N. Engl. J. Med. 1981; 305: 333–338
   Web of Science ®Google Scholar
• Gewirtz A. M., Bruno E., Elwell J., Hoffman R. In vitro studies of megakaryocytopiesis in thrombocytic disorders of man. Blood 1983; 61: 384–389
   PubMed Web of Science ®Google Scholar
• Han Z. C., Briere J., Abgrall J. F., Sensebe L., Parent D., Guern G. Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system. Exp. Hematol. 1989; 17: 46–52
   PubMed Web of Science ®Google Scholar
• Solberg L. A., Jamal N., Messner H. A. Characterization of human megakaryocytic colony formation in human plasma. J. Cell Physiol. 1985; 124: 67–74
   PubMed Web of Science ®Google Scholar
• Vainchenker W., Chapman J., Deschamps J. F., Vinci G., Bouguet J., Titeux M., Breton-Gorius J. Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formatino. Exp. Hematol. 1982; 10: 650–660
   PubMed Web of Science ®Google Scholar
• Ishibashi T., Miller S., Burstein S. A. Type β transforming growth factor is a potent inhibitor of murine megakary-ocytopoiesis in vitro. Blood 1987; 69: 1737
   PubMed Web of Science ®Google Scholar
• Solberg L. A., Tucker G. F., Grant B. W., Mann K. G., Moses H. L. Transforming growth factor-β inhibits colony formation from human megakaryocytic, erythroid, and multipotent stem cells. The inhibitors of hematopoiesis, A. Najman, M. Guignon, et al. Colloque Inserm/John Libbey Eurotext. Ltd, LondonEngland 1987; Vol 162: 111
   Google Scholar
• Mitjavila M. T., Vinci G., Villeval J. L., Kieffer N., Henri A., Testa U., Breton-Gorius J., Vainchenker W. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation. Its relationship to type β transforming growth factor (TGF-β). J. Cell Physiol. 1988; 143: 93
   Web of Science ®Google Scholar
• Han Z. C., Sensebe L., Abgrall J. F., Briere J. Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990; 75: 1234
   PubMed Web of Science ®Google Scholar
• Abgrall J. F., Han Z. C., Sensebe L., Le Gall G., Renard I., Briere J. Inhibitory effect of highly purified human platelet β-thromboglobin on in vitro human megakaryocyte colony formation. Exp. Hematol. 1991; 19: 202
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Walz D., Caen J. P. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue activating peptide III (CTAP III). Int. J. Cell Cloning 1990; 8: 253
   PubMedGoogle Scholar
• Komatsu N., Suda T., Sakata Y., Eguchi M., Kaji K., Saito M., Miura Y. Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: effect of plasma and serum on megakaryocytic colony formation. Br. J. Haematol. 1986; 64: 241–252
   PubMed Web of Science ®Google Scholar
• Han Z. C., Bellucci S., Tenza D., Caen J. P. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and β thromboglobin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythemia and immune thrombocytopenic purpura. Br. J. Haematol. 1990; 74: 395–401
   PubMed Web of Science ®Google Scholar
• Han Z. C., Maurer A. M., Bellucci S., Wan H. Y., Kroviarski Y., Bertrand O., Caen J. P. Inhibitory effect of platelet factor four (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4. J. Lab. Clin. Med. 1992; 120: 645–660
   PubMedGoogle Scholar
• Kimura H., Ishibashi T., Sato T., Matsuda S., Uchida T., Kariyone S. Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalities of bone marrow CFU-Meg. Am. J. Hematol. 1987; 24: 23–30
   PubMed Web of Science ®Google Scholar
• Juvonen E., Partanen S., Ruutu T. Colony formation by megakaryocytic progenitors in essential thrombocythaemia. Br. J. Haematol. 1987; 66: 161–164
   PubMed Web of Science ®Google Scholar
• Croizat H., Amato D., Mc Leod D. L., Eskinazi D., Axelrad A. A. Differences among myeloproliferative disorders in the behaviour of their restricted progenitor cells in culture. Blood 1983; 62: 578–584
   PubMed Web of Science ®Google Scholar
• Hibbin H. A., Njoku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br. J. Haematol. 1984; 57: 495–503
   PubMed Web of Science ®Google Scholar
• Grossi A., Vannucchi A. M., Rafanelli D., Vannucchi L., Ferrini P. R. Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Am. J. Hematol. 1987; 25: 371–376
   PubMed Web of Science ®Google Scholar
• Florensa L., Besses C., Almarcha J., Lafuente R., Palou L., Pedro C., Sans-Sabrafen J., Woessner S. Circulating erythroid andmegakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia. Eur. J. Haematol. 1989; 43: 417–422
   PubMed Web of Science ®Google Scholar
• Han Z. C., Briere J., Abgrall J. F., Sensebe L., Nedellec G., Parent D., Guern G. Spontaneous formation of megakaryocyte progenitors (CFU-MK) in primary thrombocythemia. Acta Haematol. 1987; 78: 51–53
   PubMed Web of Science ®Google Scholar
• Han Z. C. 1986
   Google Scholar
• Juvonen E., Ikkala E., Oksanen K., Ruutu T. Megakaryocyte and erythroid colony formation in essential thro-mobocythemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br. J. Haematol. 1993; 83: 192–197
   PubMed Web of Science ®Google Scholar
• Battegay E. J., Thomssen C., Nissen C., Gudat F., Speck B. Endogenous mekaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur. J. Haematol. 1989; 42: 321–326
   PubMed Web of Science ®Google Scholar
• Hetet G., Maurer A. M., Chait Y., Dhermy D., Briere J. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF. Br. J. Haematol. 1994; 87: 471–476
   PubMed Web of Science ®Google Scholar
• Lee-Ung S., Ching R. L. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood 1994; 83: 744–748
   PubMed Web of Science ®Google Scholar
• Prachl J. F., Axelrad A. A. Bone marrow responses in Polycythemia Vera. N. Engl. J. Med. 1974; 289: 132
   Google Scholar
• Lemoine F., Najman A., Baillou C., Stachowiak J., Boffa G., Aegerter P., Douay L., Laporte P., Gorin N. C., Duhamel G. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood 1986; 68: 996–1002
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Teramura M., Hoshino S., Motoji T., Oshimi K., Mizoguchi H. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Br. H. Haematol. 1993; 83: 539–544
   PubMed Web of Science ®Google Scholar
• Jiang S., Levine J. D., Fu Y., Deng B., London R., Groopman J. E., Avraham H. Cytokine production by primary bone marrow megakaryocytes. Blood 1994; 84(12)4151–4156
   PubMed Web of Science ®Google Scholar
• Wickhenhauser C., Lorenzen J., Thiele J., Hillienhof A., Jungheim K., Schmitz B., Hansmann M.-L., Fischer R. Secretion of cytokines (interleukins-1α, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes. Blood 1995; 85(3)685–691
   PubMed Web of Science ®Google Scholar
• Zauli G., Visani G., Catani L., Vianelli N., Gugliotta L., Capitani S. Reduced responsiveness of, bone marrow megakaryocyte progenitors to platelet-derived transforming growth bactor β1, produced in normal amount, in patients with essential thrombocythemia. Br. H. Haematol. 1993; 83: 14–21
   PubMed Web of Science ®Google Scholar
• Zauli G., Catani L., Gugliotta L., Gaggioli L., Vitale L., Mattioli Belmonte M., Aglietta M., Bagnara G. P. Essential thrombocythemia: impaired regulation of megakyocyte progenitors. Internat. J. Cell Cloning 1991; 9: 43–56
   PubMedGoogle Scholar
• Hetet G., Grandchamp B., Briere J. Role of proto-oncogene c-mpl in spontaneous megakaryocytopoiesis in essential thrombocythemia (Abstr.). Blood 1994; 84(10)55a
   Web of Science ®Google Scholar
• Lyon M. F. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Faguet G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Gaetani G. F., Ferraris A. M., Galiano S., Giuntini P., Canepa L., d'Urso M. Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in A GdB/GdMediterranean subject. Blood 1982; 59: 76–79
   PubMed Web of Science ®Google Scholar
• Singal U., Prasad A. S., Halton D. M., Bishop C. Essential thrombocythemia: a clonal disorder of hematopoietic stem cell. Am. J. Hematol. 1983; 14: 193–196
   PubMed Web of Science ®Google Scholar
• Raskind W. H., Jacobson R., Murphy S., Adamson J. W., Fialkow P. J. Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. J. Clin. Invest. 1985; 75: 1388–1390
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Feinberg A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985; 227: 642–645
   PubMed Web of Science ®Google Scholar
• Anger B., Janssen J. W. G., Schrezenmeier H., Hehlmann R., Heimpel H., Bartram C. R. Clonal analysis of chronic myleoproliferative disorders using X-linked DNA polymorphisms. Leukemia 1990; 4: 258–261
   PubMed Web of Science ®Google Scholar
• Janssen J. W. G., Anger B. R., Drexler H. G., Bartram C. R., Heimpel H. Essential thrombocythemia in two sisters originating from different stem cell levels. Blood 1990; 75: 1633–1636
   PubMed Web of Science ®Google Scholar
• Turhan A. G., Cashman J. D., Eaves C. J., Humphries R. K., Eaves A. C. Variable expression of features of normal and neoplastic stem cells in patients with thrombocytosis. Br. J. Haematol. 1992; 82: 50–57
   PubMed Web of Science ®Google Scholar
• Tsukamoto N., Morita K., Maehara T., Okamoto K., Sakai H., Karasawa M., Naruse T., Omine M. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement. Br. J. Haematol. 1994; 86: 253–258
   PubMed Web of Science ®Google Scholar
• Allen C., Zoghbi H. Y., Moseley A. B., Rosenblatt H. M., Belmont J. W. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlated with X-chromosome inactivation. Am J. Hum. Genet. 1992; 51: 1229–1239
   PubMed Web of Science ®Google Scholar
• Beutler E., Kuhl W. The NT 1311 polymorphism of G6PD: G6PD mediterranean mutation may have originated independently in Europe and Asia. Am. J. HuM. Genet. 1990; 47: 1008–1012
   PubMed Web of Science ®Google Scholar
• Bunge S., Steglich C., Zuther C., Beck M., Morris C. P., Schwinger E., Schinzel A., Hopwood J. J., Gal A. Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Human Molecular Genetics 1993; 2: 1871–1875
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Linch D. C. Assessment of X-chromosome inactivation patterns using the hypervariable probe M27β in normal hematopoietic cells and acute myeloid leukemic blasts. Leukemia 1992; 6: 649
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Boulos P., Linch D. C. Tissue specificity of X-chromosome inactivation patterns. Blood 1994; 83: 2899–2905
   PubMed Web of Science ®Google Scholar
• Pearson T. C. Primary thrembocythaemia: diagnosis and management. Br. J. Haematol. 1991; 78: 145–148
   PubMed Web of Science ®Google Scholar